mHealth Facilitated Intervention to Improve HIV Pre-Exposure Prophylaxis Adherence
Public ClinicalTrials.gov record NCT04990583. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
If taken every day, PrEP is an effective method for preventing HIV. However, many prescribed PrEP in the U.S. do not take it every day, as prescribed. The goal of this study is to develop and test an intervention, facilitated by a mobile app, meant to improve adherence to PrEP. To that end, 60 individuals prescribed PrEP who do not take their PrEP every day as prescribed will be recruited. Participants will complete an initial research interview, receive a one-on-one PrEP adherence session with an adherence coach, and complete follow-up interviews at 1, 3, 6, and 12 months. In addition, some participants will be randomized to receive access to a mobile app and adherence coaching via the app for 12-months. The primary outcome is self-reported adherence to PrEP. This study will examine whether this intervention is effective at improving adherence to PrEP, is feasible to use, and found acceptable by those who use it.
Study identification
- NCT ID
- NCT04990583
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- Not listed
Conditions and interventions
Interventions
- Face-to-Face PrEP Adherence Intervention Based on LifeSteps Behavioral
- Adherence Coaching Facilitated by Carium Adherence App Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2021
- Primary completion
- Mar 30, 2022
- Completion
- Jul 30, 2022
- Last update posted
- Apr 4, 2023
2021 – 2022
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Pre-Exposure Prophylaxis trials
Other public records listing Pre-Exposure Prophylaxis. Sorted by last update posted; newest first. Not a recommendation.
- NCT06183502: HIV/STD Risk and PrEP Implementation Messaging Among Gay, Bisexual, and Other Men Who Have Sex With Men Active, not recruiting
- NCT06162897: Case Management Dyad Recruiting
- NCT05753683: Gathering Online for Dialogue and Discussion to Enhance Social Support Recruiting
- NCT06487351: Intervention to Reduce Implicit Bias in Pharmacies Not yet recruiting
- NCT05929521: Centering Those Engaged in Transactional Sex: A PrEP Innovation for Getting To Zero Active, not recruiting
- NCT05165745: Stick2PrEP Cisgender Women and Trans Individuals Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04990583, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 4, 2023 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04990583 live on ClinicalTrials.gov.